Skip to main content Accessibility help
×
Home

Low serum 25-hydroxyvitamin D levels and secondary hyperparathyroidism in Fontan patients

Published online by Cambridge University Press:  17 August 2015


Finn Holler
Affiliation:
Department of Paediatric Cardiology, Heart Centre Cologne, University Hospital of Cologne, Cologne, Germany
Tobias Hannes
Affiliation:
Department of Paediatric Cardiology, Heart Centre Cologne, University Hospital of Cologne, Cologne, Germany
Ingo Germund
Affiliation:
Department of Paediatric Cardiology, Heart Centre Cologne, University Hospital of Cologne, Cologne, Germany
Mathias Emmel
Affiliation:
Department of Paediatric Cardiology, Heart Centre Cologne, University Hospital of Cologne, Cologne, Germany
Heike Hoyer-Kuhn
Affiliation:
Department of Paediatrics, Children’s Hospital, University of Cologne, Cologne, Germany
Markus Khalil
Affiliation:
Paediatric Heart Centre, Justus-Liebig University, Giessen, Germany
Narayanswami Sreeram
Affiliation:
Department of Paediatric Cardiology, Heart Centre Cologne, University Hospital of Cologne, Cologne, Germany
Floris E. A. Udink ten Cate
Affiliation:
Department of Paediatric Cardiology, Heart Centre Cologne, University Hospital of Cologne, Cologne, Germany
Corresponding

Abstract

Background

Limited data exist on the vitamin D status in Fontan patients. We determined the prevalence and potential risk factors of vitamin D deficiency in this patient subset.

Methods and results

Data were collected from 27 Fontan patients (55.6% male, mean age 8.1±5.3 years). Protein-losing enteropathy was diagnosed in six patients (22.2%). Vitamin D deficiency was defined as a serum 25-hydroxyvitamin D level of <20 ng/ml. The neutrophil-to-lymphocyte ratio, a marker of systemic inflammation, was calculated. Associations between laboratory measurements and patient characteristics were explored. Mean serum 25-hydroxyvitamin D level was 14.1±10.4 ng/ml. Vitamin D deficiency was found in 19/27 patients (70.3%). Only skin type was associated with vitamin D deficiency (p=0.04). Hyperparathyroidism was present in 5/21 (23.8%) patients, and was more prevalent in patients with protein-losing enteropathy (p<0.001). Parathyroid hormone levels correlated with parameters of systemic inflammation (neutrophil-to-lymphocyte ratio: r=0.484, p=0.026; relative lymphocyte count: r=−0.635, p=0.002). Vitamin D supplementation significantly increased serum 25-hydroxyvitamin D levels (p<0.0001), and was accompanied by a reduction in parathyroid hormone concentrations (p=0.032).

Conclusions

A high prevalence of vitamin D deficiency was found among Fontan patients, independent of age, time after Fontan procedure, ventricular morphology, and presence of protein-losing enteropathy. A potentially important link between parathyroid hormone levels and systemic inflammation is suggested.


Type
Original Articles
Copyright
© Cambridge University Press 2015 

Access options

Get access to the full version of this content by using one of the access options below.

Footnotes

Both authors contributed equally.


References

1. Cetta, F, Feldt, RH, O’Leary, PW, et al. Improved early morbidity and mortality after Fontan operation: the Mayo Clinic experience, 1987 to 1992. J Am Coll Cardiol 1996; 28: 480486.CrossRefGoogle Scholar
2. Gentles, TL, Mayer, JE Jr, Gauvreau, K, et al. Fontan operation in five hundred consecutive patients: factors influencing early and late outcome. J Thorac Cardiovasc Surg 1997; 114: 376391.CrossRefGoogle ScholarPubMed
3. Gewillig, M, Goldberg, DJ. Failure of Fontan circulation. Heart Fail Clin 2014; 10: 105116.CrossRefGoogle ScholarPubMed
4. Baek, JS, Bae, EJ, Ko, JS, et al. Late hepatic complications after Fontan operation: non-invasive markers of hepatic fibrosis and risk factors. Heart 2010; 96: 17501755.CrossRefGoogle ScholarPubMed
5. Mori, M, Aquirre, AJ, Elder, RW, et al. Beyond a broken heart: circulatory dysfunction in the failing Fontan. Pediatr Cardiol 2014; 35: 569579.CrossRefGoogle Scholar
6. Rychik, J, Goldberg, D, Rand, E, et al. End-organ consequences of the Fontan operation: liver fibrosis, protein-losing enteropathy and plastic bronchitis. Cardiol Young 2013; 23: 831840.CrossRefGoogle ScholarPubMed
7. Avitabile, CM, Leonard, MB, Zemel, BS, et al. Lean mass deficits, vitamin D status and exercise capacity in children and young adults after Fontan palliation. Heart 2014; 100: 17021707.CrossRefGoogle Scholar
8. Bulut, OP, Romero, R, Mahle, WT, et al. Magnetic resonance imaging identifies unsuspected liver abnormalities in patients after the Fontan procedure. J Pediatr 2013; 163: 201206.CrossRefGoogle ScholarPubMed
9. Giardini, A, Balducci, A, Specchia, S, Gargiulo, G, Bonvicini, M, Picchio, FM. Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients. Eur Heart J 2008; 29: 16811687.CrossRefGoogle ScholarPubMed
10. Thacker, D, Patel, A, Dodds, K, Goldberg, DJ, Semeao, E, Rychik, J. Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation. Ann Thorac Surg 2010; 89: 837842.CrossRefGoogle ScholarPubMed
11. Chin, AJ, Stephens, P, Goldmuntz, E, Leonard, MB. Serum alkaline phosphatase reflects post-Fontan hemodynamics in children. Pediatr Cardiol 2009; 30: 138145.CrossRefGoogle ScholarPubMed
12. Goldberg, DJ, Dodds, K, Avitabile, CM, et al. Children with protein-losing enteropathy after the Fontan operation are at risk for abnormal bone mineral density. Pediatr Cardiol 2012; 33: 12641268.CrossRefGoogle Scholar
13. Kim, SJ, Park, IS, Song, JY, Lee, JY, Shim, WS. Reversal of protein-losing enteropathy with calcium replacement in a patient after Fontan operation. Ann Thorac Surg 2004; 77: 14561457.CrossRefGoogle Scholar
14. Holick, MF, Binkley, NC, Bischoff-Ferrari, HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011; 96: 19111930.CrossRefGoogle ScholarPubMed
15. Misra, M, Pacaud, D, Petryk, A, Collett-Solberg, PF, Kappy, M. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 2008; 122: 398417.CrossRefGoogle ScholarPubMed
16. Norman, PE, Powell, JT. Vitamin D and cardiovascular diseases. Circ Res 2014; 114: 379393.CrossRefGoogle Scholar
17. Beigelman, A, Zeiger, RS, Mauger, D, et al. The associations between vitamin D status and rate of exacerbations requiring oral corticosteroids in preschool children with recurrent wheezing. J Allergy Clin Immunol 2014; 133: 14891492.CrossRefGoogle ScholarPubMed
18. Huibers, MH, Visser, DH, Deckers, MM, van Schoor, NM, van Furth, AM, Wolf, BH. Vitamin D deficiency among native Dutch and first- and second-generation non-western immigrants. Eur J Pediatr 2014; 173: 583588.Google ScholarPubMed
19. Kelly, A, Brooks, LJ, Dougherty, S, Carlow, DC, Zemel, BS. A cross-sectional study of vitamin D and insulin resistance in children. Arch Dis Child 2011; 96: 447452.CrossRefGoogle ScholarPubMed
20. Lee, JH, O’Keefe, JH, Bell, D, Hensrud, DD, Holick, MF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008; 52: 19491956.CrossRefGoogle ScholarPubMed
21. McNally, JD, Menon, K, Chakraborty, P, et al. The association of vitamin D status with pediatric critical illness. Pediatrics 2012; 130: 429436.CrossRefGoogle ScholarPubMed
22. McNally, JD, Sampson, M, Matheson, LA, Hutton, B, Little, J. Vitamin D receptor (VDR) polymorphisms and severe RSV bronchiolitis: a systematic review and meta-analysis. Pediatr Pulmonol 2014; 49: 790799.CrossRefGoogle ScholarPubMed
23. Schaffrath Rosario, A, Schienkiewitz, A, Neuhauser, H. German height references for children aged 0 to under 18 years compared to WHO and CDC growth charts. Ann Human Biol 2011; 38: 121130.CrossRefGoogle Scholar
24. Schaffrath Rosario, A, Kurth, BM, Stolzenberg, H, Ellert, U, Neuhauser, H. Body mass index percentiles for children and adolescents in Germany based on a nationally representative sample (KiGGS 2003-2006). Eur J Clin Nutr 2010; 64: 341349.CrossRefGoogle Scholar
25. Bergmann, KE, Mensink, GB. Anthropometric data and obesity. Gesundheitswesen 1999; 61: S115S120.Google ScholarPubMed
26. John, SA, Johnson, JA, Khan, M, Driscoll, DJ, Warnes, CA, Cetta, F. Clinical outcomes and improved survival in patients with protein-losing enteropathy after the Fontan operation. J Am Coll Cardiol 2014; 64: 5462.CrossRefGoogle ScholarPubMed
27. Uthamalingam, S, Patvardhan, EA, Subramanian, S, et al. Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. Am J Cardiol 2011; 107: 433438.CrossRefGoogle ScholarPubMed
28. Gruppen, MP, Davin, JC, Oosterveld, MJ, et al. Prevention of steroid-induced low bone mineral density in children with renal diseases: a systematic review. Nephrol Dial Transplant 2013; 28: 20992106.CrossRefGoogle ScholarPubMed
29. Liu, LC, Voors, AA, van Veldhuisen, DJ, et al. Vitamin D status and outcomes in heart failure patients. Eur J Heart Fail 2011; 13: 619625.CrossRefGoogle ScholarPubMed
30. Anderson, JL, Vanwoerkom, RC, Horne, BD, et al. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent factors? Am Heart J 2011; 162: 331339.CrossRefGoogle ScholarPubMed
31. Gandhi, S, Myers, RB. Can parathyroid hormone be used as a biomarker for heart failure? Heart Fail Rev 2013; 18: 465473.CrossRefGoogle ScholarPubMed
32. Inai, K, Nakanishi, T, Nakazawa, M. Clinical correlation and prognostic predictive value of neurohumoral factors in patients late after the Fontan operation. Am Heart J 2005; 150: 588594.CrossRefGoogle ScholarPubMed
33. Saiki, H, Kuwata, S, Kurishima, C, et al. Aldosterone-cortisol imbalance immediately after Fontan operation with implications for abnormal fluid homeostasis. Am J Cardiol 2014; 114: 15781583.CrossRefGoogle ScholarPubMed
34. Tomaschitz, A, Ritz, E, Pieske, B, et al. Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. Cardiovasc Res 2012; 94: 1019.CrossRefGoogle ScholarPubMed
35. Avgeri, M, Papadopoulou, A, Platokouki, H, et al. Assessment of bone mineral density and markers of bone turnover in children under long-term oral anticoagulant therapy. J Pediatr Hematol Oncol 2008; 30: 592597.CrossRefGoogle ScholarPubMed
36. Bendaly, EA, DiMeglio, LA, Fadel, WF, Hurwitz, RA. Bone density in children with single ventricle physiology. Pediatr Cardiol 2015; 36: 779785.CrossRefGoogle ScholarPubMed
37. Pappa, H, Thayu, M, Sylvester, F, Leonard, M, Zemel, B, Gordon, C. Skeletal health of children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2011; 53: 1125.CrossRefGoogle ScholarPubMed
38. Brown, JM, Vaidya, A. Interactions between adrenal-regulatory and calcium-regulatory hormones in human health. Curr Opin Endocrinol Diabetes Obes 2014; 21: 193201.CrossRefGoogle ScholarPubMed
39. Sharma, R, Bolger, AP, Li, W, et al. Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease. Am J Cardiol 2003; 92: 188193.CrossRefGoogle ScholarPubMed
40. Ostrow, AM, Freeze, H, Rychik, J. Protein-losing enteropathy after Fontan operation: investigations into possible pathophysiologic mechanisms. Ann Thorac Surg 2006; 82: 695700.CrossRefGoogle ScholarPubMed
41. Bode, L, Salvestrini, C, Park, PW, et al. Heparan sulphate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function. J Clin Invest 2008; 118: 229238.CrossRefGoogle ScholarPubMed
42. Chueng, YF, Tsang, HY, Kwok, JS. Immunologic profile of patients with protein-losing enteropathy complicating congenital heart disease. Pediatr Cardiol 2002; 23: 587593.CrossRefGoogle Scholar

Full text views

Full text views reflects PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.

Total number of HTML views: 13
Total number of PDF views: 135 *
View data table for this chart

* Views captured on Cambridge Core between September 2016 - 27th November 2020. This data will be updated every 24 hours.

Hostname: page-component-8465588854-mfrwq Total loading time: 1.309 Render date: 2020-11-27T12:27:37.475Z Query parameters: { "hasAccess": "0", "openAccess": "0", "isLogged": "0", "lang": "en" } Feature Flags last update: Fri Nov 27 2020 12:11:51 GMT+0000 (Coordinated Universal Time) Feature Flags: { "metrics": true, "metricsAbstractViews": false, "peerReview": true, "crossMark": true, "comments": true, "relatedCommentaries": true, "subject": true, "clr": false, "languageSwitch": true }

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Low serum 25-hydroxyvitamin D levels and secondary hyperparathyroidism in Fontan patients
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Low serum 25-hydroxyvitamin D levels and secondary hyperparathyroidism in Fontan patients
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Low serum 25-hydroxyvitamin D levels and secondary hyperparathyroidism in Fontan patients
Available formats
×
×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *